吻合器是外科手术中替代传统手工缝合的医疗器械,它主要用于对人体内各种腔道和病变组织的离断、切除、吻合以及对器官功能的重建。根据原国家食品药品监督管理总局及吻合器行业协会的研究数据,全球吻合器市场规模将由2017年的33。8亿美元增加至2022年的47。8亿美元,年增长率达到7。2%;中国吻合器市场规模由2014年的36亿元增加至2019年的107亿元,年增长率为17%。但我国吻合器行业产业集中度总体偏低,呈现小而散的状态,还没有形成规模化发展格局,并且,我国吻合器产业创新能力偏低,产品同质化严重。预计未来,手术微创化、器械操作智能化将是吻合器行业发展大势所趋,基层医院放量、区域医保覆盖将促使吻合器市场高速发展,政策扶持力度加大将更好地促进国产吻合器实现进口替代。
<<The stapling device is a medical instrument which replaces traditional manual suture in surgery. It is mainly used for dissection,resection,anastomosis and reconstruction of organ function of human body. The global stapler market will grow from $3.38 billion in 2017 to $4.78 billion in 2022,an annual growth rate of 7.2%,according to data from the Food and Drug Administration and the stapling industry association. China’s stapling market will grow from 3.6 billion yuan in 2014 to 10.7 billion yuan in 2019,an annual growth rate of 17%. However,the industry concentration degree of stapler industry in China is generally low,which appears small and scattered,and has not yet developed in scale,and the innovation ability of stapler industry is low in China,and the homogenization of products is serious. It is expected that in the future,minimally invasive surgery and intelligent equipment operation will be the trend of the development of stapler industry,grass-roots hospitals,regional medical coverage will promote the rapid development of stapler market,policy support will be increased to better domestic stapler import substitution.
<<